Antimicrobial Stewardship Advisory Committee (ASAC) Conflict of Interest Summary
The following is a list of members of the ASAC for which PHO has determined have conflicts. These declarations are provided to ensure transparency and accountability in the advisory process. Each member has disclosed any potential or actual conflicts of interest to maintain the integrity of the committee's work and ensure that recommendations are made in the best interest of public health.
|
Committee Member |
Disclosures |
|---|---|
|
Dr. Huda Almohri |
LifeLabs - Medical Microbiologist |
|
Dr. Lucas Castellani |
Gilead and Pfizer – Paid speaker engagements |
Mitigation strategy: Mitigation strategies are in place to manage each conflict individually on a case-by-case basis.
Note: This summary is intended to provide transparency regarding potential conflicts of interest for members of the ASAC. The full declarations are kept on record for internal review and reference.
PHO Rounds: From Strategy to Impact: The Role of Public Health in Advancing Antimicrobial Stewardship and Combating Antimicrobial Resistance
Drawing on the United Kingdom's (UK) experience, this PHO Rounds will explore how national public health organizations can lead and sustain antimicrobial stewardship initiatives at scale.
MyPHO
Don’t have a MyPHO account? Register Now